Please login to the form below

Not currently logged in

European Hematology Association

This page shows the latest European Hematology Association news and features for those working in and with pharma, biotech and healthcare.

New data backs J&J’s ibrutinib efficacy in B cell cancers

New data backs J&J’s ibrutinib efficacy in B cell cancers

Phase II results showcased at European Hematology Association meeting. Johnson &Johnson (J&J) and Pharmacyclics are on course to file ibrutinib in the treatment of B cell malignancies by early 2014 ... Both studies were presented at the European

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....